J Korean Med Assoc.  2012 Mar;55(3):250-258. 10.5124/jkma.2012.55.3.250.

Surgically treatable dementia

• Kim SH

• KMID: 2192715
• DOI: http://doi.org/10.5124/jkma.2012.55.3.250

Abstract

Dementia is a clinical syndrome that can be caused by multiple conditions, with variable speed of onset, rate of evolution, and duration. Some of these conditions are relentlessly progressive and ultimately fatal, some are treatable, and a few are reversible. Approximately 10% of patients are categorized as having treatable dementias, with normal pressure hydrocephalus (NPH), chronic subdural hematoma, and slow growing brain tumors being the most common etiologies. Idiopathic NPH is a typical treatable form of dementia. The invasive and non-invasive tests of cerebrospinal fluid (CSF) dynamics and drainage can provide an improved measure of postoperative outcomes. However, there is no evidence that testing is superior to clinical examination. Therefore, we should be cautious when excluding patients from shunting based on testing. Two changes in CSF circulatory physiology have been noted as part of ageing. CSF production and turnover are further diminished in patients with Alzheimer's disease (AD) and idiopathic NPH. Poor CSF clearance of proteins, such as Tau and beta amyloid, may play a role in the progression of AD. Improving CSF drainage by shunt can enhance the extracellular clearance of end products of oxidative reactions and lower brain lipid peroxidation. Recently, some efforts for treating AD have been reported. Altering the brain micro-environment to foster appropriate maturation of graft-derived neurons may be critical for improving the efficacy of neural stem cell transplantation therapy for AD. Neuroanatomic circuits mediating memory are accessible and the function of memory circuits can be modulated with neurostimulation, such as deep brain stimulation (DBS) and vagal nerve stimulation. We may identify therapeutic implications for patients with memory disorders. Such studies provide the proof of principle that DBS may remotely activate neocortical structures to enhance memory performance.

Keyword

Dementia; Normal pressure hydrocephalus; Chronic subdural hematoma; Ventriculoperitoneal shunt; Deep brain stimulation

MeSH Terms

Alzheimer Disease
Amyloid
Brain
Brain Neoplasms
Deep Brain Stimulation
Dementia
Drainage
Hematoma, Subdural, Chronic
Humans
Hydrocephalus, Normal Pressure
Lipid Peroxidation
Memory
Memory Disorders
Negotiating
Neural Stem Cells
Neurons
Proteins
Transplants
Vagus Nerve Stimulation
Ventriculoperitoneal Shunt
Amyloid
Proteins

Reference

1. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure. A treatable syndrome. N Engl J Med. 1965. 273:117–126.

2. Katzman R. Katzman R, Rowe JW, editors. Diagnosis and management of dementia. Principles of geriatric neurology. 1992. Philadelphia: Davis;167–210.

3. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D. Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypo-thesis. Lancet Neurol. 2003. 2:506–511.

4. Symon L, Dorsch NW. Use of long-term intracranial pressure measurement to assess hydrocephalic patients prior to shunt surgery. J Neurosurg. 1975. 42:258–273.

5. Sklar FH, Diehl JT, Beyer CW Jr, Clark WK. Brain elasticity changes with ventriculomegaly. J Neurosurg. 1980. 53:173–179.

6. Tamaki N, Kusunoki T, Wakabayashi T, Matsumoto S. Cerebral hemodynamics in normal-pressure hydrocephalus. Evaluation by 133Xe inhalation method and dynamic CT study. J Neurosurg. 1984. 61:510–514.

7. Kitagaki H, Mori E, Ishii K, Yamaji S, Hirono N, Imamura T. CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. AJNR Am J Neuroradiol. 1998. 19:1277–1284.

8. Algin O, Hakyemez B, Parlak M. Phase-contrast MRI and 3D-CISS versus contrast-enhanced MR cisternography on the evaluation of the aqueductal stenosis. Neuroradiology. 2010. 52:99–108.

9. Hong YJ, Yoon B, Shim YS, Cho AH, Lim SC, Ahn KJ, Yang DW. Differences in microstructural alterations of the hippocampus in Alzheimer disease and idiopathic normal pressure hydrocephalus: a diffusion tensor imaging study. AJNR Am J Neuroradiol. 2010. 31:1867–1872.

10. Ishikawa M. Guideline Committe for Idiopathic Normal Pressure Hydrocephalus, Japanese Society of Normal Pressure Hydrocephalus. Clinical guidelines for idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo). 2004. 44:222–223.

11. Marmarou A, Black P, Bergsneider M, Klinge P, Relkin N. International NPH Consultant Group. Guidelines for management of idiopathic normal pressure hydrocephalus: progress to date. Acta Neurochir Suppl. 2005. 95:237–240.

12. Black PM. Scott RM, editor. Congress of Neurological Surgeons. The normal pressure hydrocephalus syndrome. Hydrocephalus. 1990. Baltimore: Williams & Wilkins;109–114.

13. McQuarrie IG, Saint-Louis L, Scherer PB. Treatment of normal pressure hydrocephalus with low versus medium pressure cerebrospinal fluid shunts. Neurosurgery. 1984. 15:484–488.

14. Petersen RC, Mokri B, Laws ER Jr. Surgical treatment of idiopathic hydrocephalus in elderly patients. Neurology. 1985. 35:307–311.

15. Thomas-Anterion C, Moreaud O. Idiopathic normal pressure hydrocephalus. Rev Prat. 2006. 56:1051–1056.

16. Ishikawa E, Yanaka K, Sugimoto K, Ayuzawa S, Nose T. Reversible dementia in patients with chronic subdural hematomas. J Neurosurg. 2002. 96:680–683.

17. Ooba S, Shiomi N, Shigemori M. Clinical features and surgical results of chronic subdural hematoma in the extremely aged patients. No Shinkei Geka. 2006. 34:273–278.

18. Noble JM, Canoll P, Honig LS. Brain tumor-associated dementia. Sci Aging Knowledge Environ. 2005. 2005:dn2.

19. Silverberg GD, Levinthal E, Sullivan EV, Bloch DA, Chang SD, Leverenz J, Flitman S, Winn R, Marciano F, Saul T, Huhn S, Mayo M, McGuire D. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology. 2002. 59:1139–1145.

20. Pratico D, Yao Y, Rokach J, Mayo M, Silverberg GG, McGuire D. Reduction of brain lipid peroxidation by CSF drainage in Alzheimer's disease patients. J Alzheimers Dis. 2004. 6:385–389.

21. Bateman GA. The role of altered impedance in the pathophysiology of normal pressure hydrocephalus, Alzheimer's disease and syringomyelia. Med Hypotheses. 2004. 63:980–985.

22. Chakravarty A. Unifying concept for Alzheimer's disease, vascular dementia and normal pressure hydrocephalus - a hypothesis. Med Hypotheses. 2004. 63:827–833.

23. Harbaugh RE, Reeder TM, Senter HJ, Knopman DS, Baskin DS, Pirozzolo F, Chui HC, Shetter AG, Bakay RA, Leblanc R. Intracerebroventricular bethanechol chloride infusion in Alzheimer's disease. Results of a collaborative double-blind study. J Neurosurg. 1989. 71:481–486.

24. Goldsmith HS. Omental transposition in treatment of Alzheimer disease. J Am Coll Surg. 2007. 205:800–804.

25. Waldau B, Shetty AK. Behavior of neural stem cells in the Alzheimer brain. Cell Mol Life Sci. 2008. 65:2372–2384.

26. Sjogren MJ, Hellstrom PT, Jonsson MA, Runnerstam M, Silander HC, Ben-Menachem E. Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. J Clin Psychiatry. 2002. 63:972–980.

27. Merrill CA, Jonsson MA, Minthon L, Ejnell H, C-son Silander H, Blennow K, Karlsson M, Nordlund A, Rolstad S, Warkentin S, Ben-Menachem E, Sjogren MJ. Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year. J Clin Psychiatry. 2006. 67:1171–1178.

28. Hamani C, McAndrews MP, Cohn M, Oh M, Zumsteg D, Shapiro CM, Wennberg RA, Lozano AM. Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann Neurol. 2008. 63:119–123.

29. Sauvage MM, Fortin NJ, Owens CB, Yonelinas AP, Eichenbaum H. Recognition memory: opposite effects of hippocampal damage on recollection and familiarity. Nat Neurosci. 2008. 11:16–18.

30. Bischofberger J. Young and excitable: new neurons in memory networks. Nat Neurosci. 2007. 10:273–275.